(1)
Thaçi, D.; Lebwohl, M.; Warren, R. B.; Kircik, L.; Banerjee, S.; Napoli, A.; Kisa, R. M.; Linaberry, M.; Hoyt, K.; Blauvelt, A. Deucravacitinib Long-Term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin 2023, 7, s243.